1. News & Events
  2. Blog

Blog

Forum highlights innovative approaches to bolstering biomedical research

How can we — together — make research at Vanderbilt University Medical Center (VUMC) better and stronger?

That was the unifying question addressed during the second annual School of Medicine Research Enterprise Forum held Tuesday afternoon in Light Hall.

Jennifer Pietenpol, Ph.D., director of the Vanderbilt-Ingram Cancer Center and Executive Vice President for Research at VUMC, moderated the event, which highlighted several innovative approaches to bolstering biomedical research.

CTTC attends SEMDA with students

A group from CTTC attended the annual Southeastern Medical Device Association conference in Atlanta.

The conference featured a series of pitch rounds from regional medtech companies, keynote talks from the VP of Johnson & Johnson’s Medical Device Companies and the Global Head of IBM Watson Health, and a poster session featuring early stage medical devices from universities and startups.

Vanderbilt-GSK DPAc Request for Proposals

Vanderbilt-GSK DPAc Request for Proposals

Five Vanderbilt technologies earn patent protection

Five new Vanderbilt technologies earned patent protection in March.

9,605,768    Solenoid valve assembly

Vanderbilt Medical Robotic Technologies

The scope of robotics is rapidly expanding into new areas and fields. One area in which robotics is having a profound impact is medicine, most notably in the operating room.

Medical robots are able to provide surgeons with superhuman abilities including sub-millimetric accuracy, highly dexterous manipulators, and incision-less procedures.

Vanderbilt has an exceptional group of researchers who are working in this exciting field and have created some truly innovative technologies

New Vanderbilt technologies earn patent protection

Eleven new Vanderbilt technologies earned patent protection in February.

9,581,668   Multiple resonance NMR spectroscopy using a single transmitter

Vanderbilt collaborates with Boehringer Ingelheim for difficult-to-treat cancers

Boehringer Ingelheim announced a new collaboration with Vanderbilt University. The multi-year program complements an already existing collaboration by focusing on the research and development of small molecule compounds targeting the protein SOS (Son Of Sevenless). This molecule activates KRAS, a molecular switch that plays a central role in the onset of some of the deadliest cancers.

Researchers use bacteria to help control disease-carrying mosquitoes

Researchers use bacteria to help control disease-carrying mosquitoes

Vanderbilt Cardiac Innovations

Vanderbilt Cardiac Innovations

AgLaunch offers new programs to advance agricultural innovation

AgLaunch accelerates new innovations in food and agriculture. The organization addresses global issues while creating local opportunities in the Mid-South. AgLaunch connects agricultural researchers, entrepreneurs, farmers, investors, corporations and nonprofit organizations to address real farm and supply chain needs. AgLaunch is an initiative of Memphis Bioworks Foundation and the Tennessee Department of Agriculture, and includes a robust group of public and private partners including University of Tennessee Institute of Agriculture & Tennessee State University.